Stay updated on OPTIMISE Clinical Trial: Secukinumab in Psoriasis

Sign up to get notified when there's something new on the OPTIMISE Clinical Trial: Secukinumab in Psoriasis page.
Latest website image capture
Clouds background image

Latest updates to the OPTIMISE Clinical Trial: Secukinumab in Psoriasis page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    The NIH banner about agency terminology changes and related transition updates is no longer displayed above the 403 error page.
    Difference
    1%
    Check dated 2026-11-07T14:06:30.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T14:49:46.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces transition updates and says some content may use “Super Intelligence” instead of “Artificial Intelligence.”
    Difference
    1%
    Check dated 2026-10-24T15:36:15.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changes from v3.7.1 to v3.7.2; the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-17T15:21:05.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The site revision label changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T15:23:44.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Difference
    17%
    Check dated 2026-09-19T18:23:50.000Z thumbnail image

Stay in the know with updates to OPTIMISE Clinical Trial: Secukinumab in Psoriasis

Enter your email address, and we'll notify you when there's something new on the OPTIMISE Clinical Trial: Secukinumab in Psoriasis page.